Gw Pharmaceuticals reported 101.05M in Selling and Administration Expenses for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 96.79M 14.87M
Acorda Therapeutics ACOR:US $ 32.37M 100K
Adamas Pharmaceuticals ADMS:US 29.15M 2.51M
Aerie Pharmaceuticals AERI:US $ 34.54M 1.94M
Agios Pharmaceuticals AGIO:US $ 29.22M 4.34M
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
ALKERMES ALKS:US 139.19M 14.02M
Alnylam Pharmaceuticals ALNY:US $ 153.82M 1.08M
Biogen BIIB:US $ 637.3M 42.3M
Biomarin Pharmaceutical BMRN:US $ 184.16M 9.84M
Bluebird Bio BLUE:US $ 78.58M 8.3M
Clovis Oncology CLVS:US $ 32.92M 2.98M
Flexion Therapeutics FLXN:US $ 27.41M 189K
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Heron Therapeutics HRTX:US $ 33.16M 8.35M
Intercept Pharmaceuticals ICPT:US $ 57.65M 1.62M
IONIS PHARMACEUT IONS:US $ 56.46M 4.74M
Moderna Inc MRNA:US 121M 44M
Neurocrine Biosciences NBIX:US $ 143.2M 14.2M
Prothena PRTA:US 11.03M 93K
Ptc Therapeutics PTCT:US $ 68.88M 7.78M
Puma Biotechnology PBYI:US $ 39.41M 11.17M
Regeneron Pharmaceuticals REGN:US $ 414.7M 9.1M
Sarepta Therapeutics SRPT:US $ 72.35M 1.22M
Ultragenyx Pharmaceutical RARE:US $ 53.41M 152K
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
YTE INCY:US $ 168.86M 15.06M
Zogenix ZGNX:US $ 33.88M 2.61M